Benjamin Graham fit · Defensive deep-value investing
Is Tandem Diabetes Care, Inc. (TNDM) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
16/100
FNot a fit
3/7 criteria passed
Benjamin Graham's Criteria, Applied to TNDM
P/E ≤ 15
key—
P/B ≤ 1.5
key0.0x
Current ratio ≥ 2
2.4x
Debt / Equity ≤ 1
0.0x
5y profitable
keyNo
Earnings yield ≥ 7%
-14.6%
Revenue growing
-20.3%
How TNDM Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.31B
P/E (TTM)
-
ROIC (TTM)
-8.44%
Gross margin
54.93%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is TNDM's Benjamin Graham fit score?
TNDM scores 16/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own TNDM?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends TNDM.
How often is this score updated?
TNDM's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends TNDM.